Interferon α2b augments suppressed immune functions in tobacco-related head and neck squamous cell carcinoma patients by modulating cytokine signaling

Oral Oncology

Volumn 42, Issue 2, 2006, Pages 161-171

  Bose, Anamika ^a   Ghosh, Diptendu ^a   Pal, Smarajit ^a   Mukherjee, Kalyan K ^a   Biswas, Jaydip ^a   Baral, Rathindranath ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

Author keywords

Cytokine; Cytotoxicity; Head and neck squamous cell carcinoma (HNSCC); Interferon 2b (IFN 2b); Peripheral blood mononuclear cell (PBMC); Tobacco

Indexed keywords

ALPHA2B INTERFERON; CISPLATIN; CYTOKINE; FLUOROURACIL; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; LACTATE DEHYDROGENASE; SHANFERON; STAT1 PROTEIN; STAT4 PROTEIN;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; CELL STRAIN K 562; CELL STRAIN KB; CELL STRAIN MCF 7; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFICACY; FEMALE; HEAD AND NECK CANCER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TH1 CELL; TH2 CELL; TOBACCO; TONGUE CARCINOMA; CELL ADHESION; CELL CULTURE; HEAD AND NECK TUMOR; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE COUNT; MACROPHAGE ACTIVATION; MIDDLE AGED; T LYMPHOCYTE SUBPOPULATION; TOBACCO DEPENDENCE;

ADULT; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNE TOLERANCE; INTERFERON ALFA-2B; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; MACROPHAGE ACTIVATION; MALE; MIDDLE AGED; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; TOBACCO USE DISORDER; TUMOR CELLS, CULTURED;

EID: 30844451807     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2005.06.025     Document Type: Article

References (31)

1. J.K. Nagpal, R. Mishra, and B.R. Das Activation of Stat-3 as one of the early events in tobacco chewing-mediated oral carcinogenesis Cancer 94 9 2002 2393 2400
2. R.N. Baral, S. Patnaik, and B.R. Das Co-overexpression of p53 and c-myc proteins linked with advanced stages of betel- and tobacco-related oral squamous cell carcinomas from eastern India Eur J Oral Sci 106 5 1998 907 913
3. Mohanty L. Smokeless tobacco and oral cancer: an epidemiological study in Orissa. M.Phil. thesis. Utkal University, India, 1993.
4. Z.P. Pavelic, M. Lasmar, and L. Pavelic Absence of retinoblastoma gene product in human primary oral cavity carcinomas Eur J Cancer B Oral Oncol 32B 5 1996 347 351
5. Z. Chen, P.S. Malhotra, and G.R. Thomas Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer Clin Cancer Res 5 6 1999 1369 1379
6. S.P. Schantz, and L. Poisson Natural killer cell response to regional lymph node metastases Arch Otolaryngol Head Neck Surg 112 5 1986 545 551
7. P.J. Simons, R.A. Oostendorp, M.P. Tas, and H.A. Drexhage Comparison of retroviral p15E-related factors and interferon alpha in head and neck cancer Cancer Immunol Immunother 38 3 1994 178 184
8. T.Y. Shibuya, S. Kim, and K. Nguyen Covalent linking of proteins and cytokines to suture: enhancing the immune response of head and neck cancer patients Laryngoscope 113 11 2003 1870 1884
9. J.E. Talmadge, R.B. Herberman, and M.A. Chirigos Hyporesponsiveness to augmentation of murine natural killer cell activity in different anatomical compartments by multiple injections of various immunomodulators including recombinant interferons and interleukin-2 J Immunol 135 4 1985 2483 2488
10. J. Knop, B. Taborski, and J. DeMaeyer-Guignard Selective inhibition of the generation of T suppressor cells of contact sensitivity in vitro by interferon J Immunol 138 11 1987 3684 3687
11. B.D. Chen, and F. Najor Macrophage activation by interferon α + β is associated with a loss of proliferative capacity: role of interferon α + β in the regulation of macrophage proliferation and function Cell Immunol 106 2 1987 343 354
12. D.J. Linder Interferons as antiangiogenic agents Curr Oncol Rep 4 6 2002 510 514
13. T. Nataoka, N. Matsuura, F. Oh-hashi, and Y. Suhara Treatment regimen and host T-cell-dependent therapeutic effect of interferon in mouse solid tumors Cancer Res 45 8 1985 3548 3553
14. S. Walder, E.L. Schwartz, and M. Goldman Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review Cancer Res 50 12 1990 3473 3486
15. A. Gotoh, T. Shirakawa, and N. Hinata Long-term outcome of post operative interferon-alpha adjuvant therapy for non-metastatic renal cell carcinoma Int J Urol 11 5 2004 257 263
16. G. Alatrash, T.E. Hutson, and L. Molto Clinical and immunologic effects of subcutaneously administrated interleukin-12 and interferon alfa-2b: phase I trial of patients with metastatic renal cell carcinoma or malignant melanoma J Clin Oncol 22 14 2004 2891 2900
17. A. Aviles, N. Neri, J. Huerta-Guzman, F. Perez, and L. Sotelo Interferon alpha 2b as maintenance therapy improves outcome in follicular lymphoma Leukemia and Lymphoma 45 11 2004 2247 2251
18. D.R. Vlock, J. Johnson, and E. Myers Preliminary trial of nonrecombinant interferon alpha in recurrent squamous cell carcinoma of the head and neck Head Neck 13 1 1991 15 21
19. J.K. Peng, J.S. Lin, J.T. Kung, F.D. Finkelman, and B.A. Wu-Hsieh The combined effect of IL-4 and IL-10 suppresses the generation of, but does not change the polarity of, type-1 T cells in Histoplasma Int Immunol 17 10 2005 193 205
20. W. Zhang, J.L. Liu, A. Meager, J. Newsom-Davis, and N. Willcox Autoantibodies to IL-12 in myasthenia gravis patients with thymoma; effects on the IFN-gamma responses of healthy CD4+ T cells J Neuroimmunol 139 1-2 2003 102 108
21. T. Luft, P. Luetjens, and H. Hochrein IFN-alpha enhances CD40 ligand-mediated activation of immature monocyte-derived dendridic cells Int Immunol 14 4 2002 367 380
22. S. Matikainen, A. Paananen, and M. Miettinen IFN-alpha and IL-18 synergistically enhance IFN-gamma production in human NK cells: differential regulation of Stat4 activation and IFN-gamma gene expression by IFN-alpha and IL-12 Eur J Immunol 31 7 2001 2236 2245
23. M.A. Freudenberg, T. Merlin, C. Kalis, Y. Chvatchko, H. Stubig, and C. Galanos Cutting edge: a murine, IL-12-independent pathway of IFN-gamma induction by gram-negative bacteria based on STAT4 activation by Type I IFN and IL-18 signaling J Immunol 169 4 2002 1665 1668
24. L.C. Gavrilescu, B.A. Butcher, L. Del Rio, G.A. Taylor, and E.Y. Denkers STAT1 is essential for antimicrobial effector function but dispensable for gamma interferon production during Toxoplasma gondii infection Infect Immunol 72 3 2004 1257 1264
25. K.B. Nguyen, T.P. Salazar-Mather, and M.Y. Dalod Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection J Immunol 169 8 2002 4279 4287
26. H. Harada, M. Matsumoto, and Y. Kashiwazaki Regulation of IFN-alpha/beta genes: evidence for a dual function of the transcription factor complex ISGF3 in the production and action of IFN-alpha/beta Genes Cells 11 1 1996 995 1005
27. C.M. Coughlin, K.E. Salhay, and M.S. Gee Tumor cell responses to IFNγ affect tumorigenicity and response to IL-12 therapy and antiangiogenesis Immunity 9 1 1998 25 34
28. A. Billieu, H. Heremans, K. Vermeire, and P. Matthys Immunomodulatory properties of interferon γ: an update Ann NY Acad Sci 856 1998 22 32
29. C. Berthou, J.F. Bourge, and Y. Zhang Interferon-γ induced membrane PSF-receptor expression confers tumors cell susceptibility to NK perforin dependent lysis Blood 95 7 2000 2329 2336
30. I. Stepanov, S.S. Hecht, S. Ramakrishnan, and P.C. Gupta Tobaco-specific nitrosamines in smokeless tobacco products marketed in India Int J Cancer 116 1 2005 16 19
31. S. Thomas, J. Brennan, and G. Martel Mutation in the conserved regions of p53 are infrequent in betel-associated oral cancers from Papua New Guinea Cancer Res 54 13 1994 3588 3593